{"id":60174,"date":"2024-10-15T19:04:41","date_gmt":"2024-10-15T17:04:41","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/"},"modified":"2024-10-15T19:04:41","modified_gmt":"2024-10-15T17:04:41","slug":"namsa-and-terumo-announce-strategic-outsourcing-partnership","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/","title":{"rendered":"NAMSA and TERUMO Announce Strategic Outsourcing Partnership"},"content":{"rendered":"
\n

\nNAMSA\u2019s clinical research, testing and consulting services will help accelerate the regulatory approval of TERUMO\u2019s medical device portfolio on a global level.<\/i><\/b>\n<\/p>\n

<\/a>
<\/a><\/p>\n

TOLEDO, Ohio & TOKYO–(BUSINESS WIRE)–#AdvaMed<\/a>—NAMSA<\/a>, a world-leading MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO<\/a>, a global leader in medical technology, announced that they have entered into a strategic outsourcing partnership aimed at accelerating the regulatory approval and commercialization of Terumo\u2019s product portfolio.\n<\/p>\n

\nBased in Tokyo and operating globally, Terumo provides innovative medical solutions in more than 160 countries and regions. Its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments.\n<\/p>\n

\n\u201cWe are thrilled to facilitate Terumo\u2019s growth through this strategic outsourcing partnership,\u201d explained John Amat, NAMSA Chief Commercial Officer. \u201cAs part of this partnership, we have granted Terumo immediate access to clinical experts for study starts and capacity in addition to our skilled and talented teams of clinical and regulatory medical device experts. Together, we\u2019ll accelerate the introduction of life-enhancing devices.\u201d\n<\/p>\n

\nThe global MedTech industry is experiencing changing regulatory requirements<\/a> and increasing clinical evidence<\/a> demands. More stringent requirements can extend development timelines, increase costs and slow speed-to-market. NAMSA’s strategic outsourcing solution and full suite of in-house services (clinical, preclinical, testing, regulatory) allows MedTech innovators to proactively mitigate risk, preserve capital and create more stakeholder value. This results in accelerated commercialization and products that are more readily available to patients that need them most.\n<\/p>\n

\nToshihiko Osada, Group Senior Managing Executive Officer, Terumo Corporation commented, \u201cWe strongly believe that the establishment of a global strategic partnership with NAMSA will enable us to realize a seamless, end-to-end development program that covers from feasibility studies to product launches on a global scale. This partnership is a pivotal step toward bringing cutting-edge technology and innovation to physicians and patients worldwide and we are excited about the journey ahead.\u201d\n<\/p>\n

\nABOUT NAMSA<\/span><\/b>\n<\/p>\n

\nHelping medical device Sponsors improve healthcare since 1967, NAMSA is the world\u2019s leading MedTech Contract Research Organization (CRO) offering end-to-end services. Driven by its global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients\u2019 products through the product development lifecycle efficiently and cost-effectively. From preclinical and clinical research to medical device testing and regulatory compliance, NAMSA is the industry\u2019s premier, trusted partner for successful development and commercialization outcomes. Web: namsa.com<\/a>\n<\/p>\n

\nABOUT TERUMO<\/span><\/b>\n<\/p>\n

\nTerumo (TSE: 4543) is a global leader in medical technology and has been committed to \u201cContributing to Society through Healthcare\u201d for more than 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nNAMSA Media Contact<\/span><\/b>
Chris Rupp
\n
Vice President Global Marketing & Commercial Operations
\n
Email: crupp@namsa.com<\/a><\/p>\n

Terumo Media Contact<\/span><\/b>
Kazuki Yamamoto
\n
General Manager, Corporate Communication Department
\n
Email: kazuki_yamamoto@terumo.co.jp<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NAMSA\u2019s clinical research, testing and consulting services will help accelerate the regulatory approval of TERUMO\u2019s medical device portfolio on a global level. TOLEDO, Ohio & TOKYO–(BUSINESS WIRE)–#AdvaMed—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO, a global leader in medical technology, announced that they have entered into a strategic … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60174","6":"format-standard","7":"category-industry"},"yoast_head":"\nNAMSA and TERUMO Announce Strategic Outsourcing Partnership - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NAMSA and TERUMO Announce Strategic Outsourcing Partnership - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NAMSA\u2019s clinical research, testing and consulting services will help accelerate the regulatory approval of TERUMO\u2019s medical device portfolio on a global level. TOLEDO, Ohio & TOKYO–(BUSINESS WIRE)–#AdvaMed—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO, a global leader in medical technology, announced that they have entered into a strategic ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-15T17:04:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20241015113976\/en\/667069\/22\/NamsaLogo-1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NAMSA and TERUMO Announce Strategic Outsourcing Partnership\",\"datePublished\":\"2024-10-15T17:04:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/\"},\"wordCount\":577,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241015113976\\\/en\\\/667069\\\/22\\\/NamsaLogo-1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/\",\"name\":\"NAMSA and TERUMO Announce Strategic Outsourcing Partnership - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241015113976\\\/en\\\/667069\\\/22\\\/NamsaLogo-1.jpg\",\"datePublished\":\"2024-10-15T17:04:41+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241015113976\\\/en\\\/667069\\\/22\\\/NamsaLogo-1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20241015113976\\\/en\\\/667069\\\/22\\\/NamsaLogo-1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/namsa-and-terumo-announce-strategic-outsourcing-partnership\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NAMSA and TERUMO Announce Strategic Outsourcing Partnership\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NAMSA and TERUMO Announce Strategic Outsourcing Partnership - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/","og_locale":"en_US","og_type":"article","og_title":"NAMSA and TERUMO Announce Strategic Outsourcing Partnership - Pharma Trend","og_description":"NAMSA\u2019s clinical research, testing and consulting services will help accelerate the regulatory approval of TERUMO\u2019s medical device portfolio on a global level. TOLEDO, Ohio & TOKYO–(BUSINESS WIRE)–#AdvaMed—NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering end-to-end market access services, and TERUMO, a global leader in medical technology, announced that they have entered into a strategic ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/","og_site_name":"Pharma Trend","article_published_time":"2024-10-15T17:04:41+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20241015113976\/en\/667069\/22\/NamsaLogo-1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NAMSA and TERUMO Announce Strategic Outsourcing Partnership","datePublished":"2024-10-15T17:04:41+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/"},"wordCount":577,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241015113976\/en\/667069\/22\/NamsaLogo-1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/","url":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/","name":"NAMSA and TERUMO Announce Strategic Outsourcing Partnership - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20241015113976\/en\/667069\/22\/NamsaLogo-1.jpg","datePublished":"2024-10-15T17:04:41+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20241015113976\/en\/667069\/22\/NamsaLogo-1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20241015113976\/en\/667069\/22\/NamsaLogo-1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/namsa-and-terumo-announce-strategic-outsourcing-partnership\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NAMSA and TERUMO Announce Strategic Outsourcing Partnership"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60174","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60174"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60174\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60174"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60174"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60174"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}